SPINEART SA
6 recall(s) on record — most severe on record: Class II.
Recalls by year
- Recalls (6)
Registered facilities (2)
- SPINEART SA FEI 3007728266 · CH
- ALPES CN SAS FEI 3037407500 · FR
Recalls & enforcement
- Class IIOngoing2025-06-30Cannulated fenestrated polyaxial screws may be incorrectly labeled
- Class IIOngoing2024-03-15Due to receiving information regarding difficulties with the insertion of a setscrew inside a screw head. Issues involved, either: 1. The setscrew is not tightened to torque 2. The setscrew is tightened to torque but position askew
- Class IIOngoing2023-03-16JULIET Lateral Lumbar Ti-Life Plate, a component of the JULIET Ti Lateral Lumbar Cage, may disassemble during the preparation stage before implantation, or during surgery when removing the implant holder, which could cause surgical delay.
- Class IITerminated2021-04-09Due to external labelling error/mix-up. Affected product external labels list the incorrect rod size.
- Class IIITerminated2019-02-05Inner blister pack label is incorrect and does not match the correct external box label.
- Class IITerminated2017-11-27Product labeling for TRYPTIK 2-C-PLATE Self Tapping screw, REF TRY-PS 40, Lot 3-5934 contains the sketch/drawing of a self-drilling screw.
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. We restate the public record only — measured facts, never risk verdicts.
Cite this record
RegWarden. “SPINEART SA — FDA compliance profile.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/company/oo-10028947-spineart-sa/
Alerts for SPINEART SA
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.